DexCom
DXCM
#877
Rank
NZ$47.75 B
Marketcap
NZ$122.45
Share price
-0.23%
Change (1 day)
-22.73%
Change (1 year)

Earnings for DexCom (DXCM)

Earnings in 2024: NZ$1.21 Billion

According to DexCom's latest financial reports the company's current earnings are NZ$4.51 Billion. In 2024 the company made an earning of NZ$1.21 Billion a decrease over its 2023 earnings that were of NZ$1.22 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for DexCom from 2005 to 2024

Annual earnings

Year Earnings Change
2024NZ$1.21 B-0.37%
2023NZ$1.22 B78.13%
2022NZ$0.68 B47.34%
2021NZ$0.46 B-10.11%
2020NZ$0.51 B88.27%
2019NZ$0.27 B-258.48%
2018-NZ$0.18 Billion189.94%
2017-NZ$59.98 Million-44.24%
2016-NZ$0.11 Billion12.43%
2015-NZ$95.67 Million165.58%
2014-NZ$36.03 Million-25.61%
2013-NZ$48.42 Million-48.11%
2012-NZ$93.32 Million24.5%
2011-NZ$74.95 Million
2008-NZ$88.51 Million13.18%
2007-NZ$78.21 Million-5.36%
2006-NZ$82.64 Million52.08%
2005-NZ$54.34 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
NZ$54.27 B 3,212.47%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
NZ$13.63 B 732.11%๐Ÿ‡บ๐Ÿ‡ธ USA
Medtronic
MDT
NZ$10.73 B 555.42%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Becton Dickinson
BDX
NZ$3.15 B 92.43%๐Ÿ‡บ๐Ÿ‡ธ USA
Edwards Lifesciences
EW
NZ$2.85 B 74.54%๐Ÿ‡บ๐Ÿ‡ธ USA
Tandem Diabetes Care
TNDM
-NZ$0.35 Billion-120.95%๐Ÿ‡บ๐Ÿ‡ธ USA
QuidelOrtho
QDEL
-NZ$1.91 Billion-216.18%๐Ÿ‡บ๐Ÿ‡ธ USA
West Pharmaceutical Services
WST
NZ$1.01 B-38.21%๐Ÿ‡บ๐Ÿ‡ธ USA